Viewing Study NCT02693535


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-02-20 @ 6:04 PM
Study NCT ID: NCT02693535
Status: RECRUITING
Last Update Posted: 2025-08-26
First Post: 2016-02-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Sponsor: American Society of Clinical Oncology
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Pro00014171
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View
None INDUSTRY View